Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome
- 25 May 2011
- journal article
- research article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 23 (8) , 754-e332
Abstract
The 5-HT(4) receptor agonist, mosapride citrate, accelerates gastric emptying. However, the effect of mosapride on colonic function has not been well investigated. We examined whether mosapride changes rectosigmoid motility and perception in patients with irritable bowel syndrome (IBS). Thirty-seven patients with IBS and 18 healthy subjects were studied. All subjects underwent a rectosigmoid barostat test to measure pain perception to intraluminal distention and resting smooth muscle motility for 20 min in the fasting state. Irritable bowel syndrome patients were then randomly assigned to receive either mosapride 15 mg (n=19) or placebo (n=18) orally with 200 mL water. Rectosigmoid motility and perception were measured again for 60 min following dosing. Rectosigmoid tone and contractility were evaluated in each 10-min period. The pain threshold in the patients was significantly lower than that in controls (P<0.01). There were no differences between mosapride and placebo groups in pain threshold, barostat bag volume, or number of contractions at baseline. Mosapride significantly decreased the mean bag volume (P<0.01; group × period interaction by two-way anova) and increased the mean number of contractions (P<0.05) compared with placebo, but did not affect the perception. In IBS patients with constipation (i.e., excluding diarrhea-predominant subjects), mosapride (n=13) increased rectosigmoid tone (P<0.01) and contractions (P<0.05) more than placebo (n=14). Mosapride stimulates colonic motility without any adverse effect. These findings suggest that mosapride may have the potential to treat IBS patients with constipation and/or functional constipation. Further clinical trials are warranted to confirm the efficacy of this agent.Keywords
This publication has 35 references indexed in Scilit:
- The effect of mosapride citrate on constipation in patients with diabetesDiabetes Research and Clinical Practice, 2010
- Contributions of Pain Sensitivity and Colonic Motility to IBS Symptom Severity and Predominant Bowel HabitsAmerican Journal of Gastroenterology, 2008
- MosaprideDrugs, 2008
- Importance of 5‐hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivityNeurogastroenterology & Motility, 2007
- The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI DisordersGastroenterology, 2007
- Drugs Acting on Serotonin Receptors for the Treatment of Functional GI DisordersDigestive Diseases, 2006
- Mosapride citrate, a novel 5‐HT4 agonist and partial 5‐HT3 antagonist, ameliorates constipation in parkinsonian patientsMovement Disorders, 2005
- Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathyDiabetes Research and Clinical Practice, 2003
- AGA technical review on irritable bowel syndromeGastroenterology, 2002
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996